HomeInvestingEarningsLLY Beats Earnings & Wegovy Could Reduce Cardiovascular Events

LLY Beats Earnings & Wegovy Could Reduce Cardiovascular Events

Eli Lilly (LLY) earnings were released today, premarket. Its adjusted EPS came in at $2.11 versus an estimated $1.98 and its revenue came in at $8.31B versus an estimated $7.55B. Caroline Woods discusses this along with Novo Nordisk (NVO). NVO announced that its weight loss drug, Wegovy has been found to reduce cardiovascular events. The trial included overweight and obese patients. NVO expects to see U.S. and E.U. regulatory approval before the end of 2023. Tune in to find out more about the stock market today.

Morning Trade Live

08 Aug 2023

SHARE

ON AIR
8:30 pm
Fast Market
replay
12:00 am
Fast Market
REPLAY
1:00 am
Trading 360
REPLAY
2:00 am
Next Gen Investing
REPLAY
education
3:00 am
Your First Trade
REPLAY
3:30 am
Trading 360
REPLAY
4:30 am
Next Gen Investing
REPLAY
education
5:30 am
Your First Trade
REPLAY
6:00 am
Fast Market
REPLAY
7:00 am
Futures
8:00 am
Morning Trade Live
10:00 am
Trading 360
11:00 am
Fast Market
12:00 pm
Next Gen Investing
1:00 pm
The Watch List
2:00 pm
Market On Close
education
3:30 pm
Your First Trade
4:00 pm
Trading 360
REPLAY
5:00 pm
Fast Market
REPLAY
6:00 pm
Next Gen Investing
REPLAY
education
7:00 pm
Your First Trade
REPLAY
7:30 pm
Trading 360
REPLAY
ON AIR
8:30 pm
Fast Market
REPLAY
9:30 pm
Next Gen Investing
REPLAY
education
10:30 pm
Your First Trade
REPLAY
11:00 pm
Trading 360
REPLAY

Get the Market Minute

Daily insights for every investor

coming soon

We are now

coming soon

We are now